Euroimmun founder Stöcker: “essential message is beyond any question”
Euroimmun founder Winfried Stöcker replies to criticism of his company’s publications: “Dr. Elisabeth Bik’s observations are not suitable to bring us into disrepute.”
Author: Leonid Schneider
Independent Science Journalist and Cartoonist.
Formerly molecular cell biologist. My academic CV at: https://orcid.org/0000-0002-6204-9470
The wizard men curing breast cancer
A breast cancer foundation celebrates its research heroes. Read now here about how great US scientists from Harvard, MIT, Weill Cornell and MD Anderson cure cancer.
Fixing science: with climate denial, misogyny and white supremacism?
A conservative think tank organises a research integrity conference to prove climate change is not real. It is a white men-only academic event, and there are good reasons for that.
Magic crystals and Nobel Science rules
As one Nobelist retracted her Science paper, another Nobelist has stealthily corrected his. The correction opens new dimensions of probabilities and is indeed best kept hidden.
Euroimmun: Graphic Art, Made in Germany
EuroImmun is a German diagnostics biotech, founded by the most charming Professor Stöcker and recently sold to PerkinElmer. Elisabeth Bik checked some of company’s papers, many coauthored by Stöcker himself, and she raised questions. The company says this “testifies to a lack of knowledge of the matter”.
Bah Humbug
Edinburgh psychologists announce in Nature Communications genes for being rich. A Christmas Carol.
Aguzzi and the Lowlifes
The prion researcher Adriano Aguzzi used to describe his Pubpeer critics as “lowlifes”, and himself as a victim of a lynch mob. But after Elisabeth Bik helped him find even more mistakes in his papers, Aguzzi changed his stance.
Reddy vs JBC
Pittsburgh associate professor Raju Reddy and a colleague sued JBC over a retraction. The case has been settled in January 2021, the baddies won and the precedent is set.
Catherine Verfaillie, the Zombie Scientist of KU Leuven
Catherine Verfaillie is a zombie scientist: her past stem cell research long discredited, but she still is an influential and very well funded star of Belgian science. Now Elisabeth Bik had a fresh new look at Verfaillie’s papers
The Lancet, UNSW and Khachigian’s cancer cure
A dishonest cancer researcher. A dud cancer drug based on rigged lab data. A clinical trial in The Lancet. A greedy university which finds no misconduct. And a medical journal which tramples over patients.
For Better Science 